Global New Psychoactive Substance Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Description

The New Psychoactive Substance market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global New Psychoactive Substance size is estimated to be USD  million in 2026 from USD  million in 2020, with a change  % between 2020 and 2021. The global New Psychoactive Substance market size is expected to grow at a CAGR of  % for the next five years.

Market segmentation
New Psychoactive Substance market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Stimulants
    Cannabinoids
    Hallucinogens
    Depressants

Market segment by Application, can be divided into
    Cancer
    Neuropathic Disorders
    Spasticity
    Others

Market segment by players, this report covers
    Zynerba Pharmaceuticals
    GW Pharmaceuticals
    Teewinot Life Sciences
    AusCann
    Cannabics Pharmaceuticals
    Tilray
    Cyrelian
    Anandia Laboratories
    InMed Pharmaceuticals
    Renew Biopharma
    Cronos Group
    ICC International Cannabis
    Biotii Technologies

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe New Psychoactive Substance product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of New Psychoactive Substance, with revenue, gross margin and global market share of New Psychoactive Substance from 2019 to 2021.
Chapter 3, the New Psychoactive Substance competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and New Psychoactive Substance market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe New Psychoactive Substance research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of New Psychoactive Substance
    1.2 Classification of New Psychoactive Substance by Type
        1.2.1 Overview: Global New Psychoactive Substance Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global New Psychoactive Substance Revenue Market Share by Type in 2020
        1.2.3 Stimulants
        1.2.4 Cannabinoids
        1.2.5 Hallucinogens
        1.2.6 Depressants
    1.3 Global New Psychoactive Substance Market by Application
        1.3.1 Overview: Global New Psychoactive Substance Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Cancer
        1.3.3 Neuropathic Disorders
        1.3.4 Spasticity
        1.3.5 Others
    1.4 Global New Psychoactive Substance Market Size & Forecast
    1.5 Global New Psychoactive Substance Market Size and Forecast by Region
        1.5.1 Global New Psychoactive Substance Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global New Psychoactive Substance Market Size by Region, (2016-2021)
        1.5.3 North America New Psychoactive Substance Market Size and Prospect (2016-2026)
        1.5.4 Europe New Psychoactive Substance Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific New Psychoactive Substance Market Size and Prospect (2016-2026)
        1.5.6 South America New Psychoactive Substance Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa New Psychoactive Substance Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 New Psychoactive Substance Market Drivers
        1.6.2 New Psychoactive Substance Market Restraints
        1.6.3 New Psychoactive Substance Trends Analysis

2 Company Profiles
    2.1 Zynerba Pharmaceuticals
        2.1.1 Zynerba Pharmaceuticals Details
        2.1.2 Zynerba Pharmaceuticals Major Business
        2.1.3 Zynerba Pharmaceuticals New Psychoactive Substance Product and Solutions
        2.1.4 Zynerba Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Zynerba Pharmaceuticals Recent Developments and Future Plans
    2.2 GW Pharmaceuticals
        2.2.1 GW Pharmaceuticals Details
        2.2.2 GW Pharmaceuticals Major Business
        2.2.3 GW Pharmaceuticals New Psychoactive Substance Product and Solutions
        2.2.4 GW Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 GW Pharmaceuticals Recent Developments and Future Plans
    2.3 Teewinot Life Sciences
        2.3.1 Teewinot Life Sciences Details
        2.3.2 Teewinot Life Sciences Major Business
        2.3.3 Teewinot Life Sciences New Psychoactive Substance Product and Solutions
        2.3.4 Teewinot Life Sciences New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Teewinot Life Sciences Recent Developments and Future Plans
    2.4 AusCann
        2.4.1 AusCann Details
        2.4.2 AusCann Major Business
        2.4.3 AusCann New Psychoactive Substance Product and Solutions
        2.4.4 AusCann New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 AusCann Recent Developments and Future Plans
    2.5 Cannabics Pharmaceuticals
        2.5.1 Cannabics Pharmaceuticals Details
        2.5.2 Cannabics Pharmaceuticals Major Business
        2.5.3 Cannabics Pharmaceuticals New Psychoactive Substance Product and Solutions
        2.5.4 Cannabics Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Cannabics Pharmaceuticals Recent Developments and Future Plans
    2.6 Tilray
        2.6.1 Tilray Details
        2.6.2 Tilray Major Business
        2.6.3 Tilray New Psychoactive Substance Product and Solutions
        2.6.4 Tilray New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Tilray Recent Developments and Future Plans
    2.7 Cyrelian
        2.7.1 Cyrelian Details
        2.7.2 Cyrelian Major Business
        2.7.3 Cyrelian New Psychoactive Substance Product and Solutions
        2.7.4 Cyrelian New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Cyrelian Recent Developments and Future Plans
    2.8 Anandia Laboratories
        2.8.1 Anandia Laboratories Details
        2.8.2 Anandia Laboratories Major Business
        2.8.3 Anandia Laboratories New Psychoactive Substance Product and Solutions
        2.8.4 Anandia Laboratories New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Anandia Laboratories Recent Developments and Future Plans
    2.9 InMed Pharmaceuticals
        2.9.1 InMed Pharmaceuticals Details
        2.9.2 InMed Pharmaceuticals Major Business
        2.9.3 InMed Pharmaceuticals New Psychoactive Substance Product and Solutions
        2.9.4 InMed Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 InMed Pharmaceuticals Recent Developments and Future Plans
    2.10 Renew Biopharma
        2.10.1 Renew Biopharma Details
        2.10.2 Renew Biopharma Major Business
        2.10.3 Renew Biopharma New Psychoactive Substance Product and Solutions
        2.10.4 Renew Biopharma New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Renew Biopharma Recent Developments and Future Plans
    2.11 Cronos Group
        2.11.1 Cronos Group Details
        2.11.2 Cronos Group Major Business
        2.11.3 Cronos Group New Psychoactive Substance Product and Solutions
        2.11.4 Cronos Group New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Cronos Group Recent Developments and Future Plans
    2.12 ICC International Cannabis
        2.12.1 ICC International Cannabis Details
        2.12.2 ICC International Cannabis Major Business
        2.12.3 ICC International Cannabis New Psychoactive Substance Product and Solutions
        2.12.4 ICC International Cannabis New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 ICC International Cannabis Recent Developments and Future Plans
    2.13 Biotii Technologies
        2.13.1 Biotii Technologies Details
        2.13.2 Biotii Technologies Major Business
        2.13.3 Biotii Technologies New Psychoactive Substance Product and Solutions
        2.13.4 Biotii Technologies New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Biotii Technologies Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global New Psychoactive Substance Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 New Psychoactive Substance Players Market Share
        3.2.2 Top 10 New Psychoactive Substance Players Market Share
        3.2.3 Market Competition Trend
    3.3 New Psychoactive Substance Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global New Psychoactive Substance Revenue and Market Share by Type (2016-2021)
    4.2 Global New Psychoactive Substance Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global New Psychoactive Substance Revenue Market Share by Application (2016-2021)
    5.2 New Psychoactive Substance Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America New Psychoactive Substance Revenue by Type (2016-2026)
    6.2 North America New Psychoactive Substance Revenue by Application (2016-2026)
    6.3 North America New Psychoactive Substance Market Size by Country
        6.3.1 North America New Psychoactive Substance Revenue by Country (2016-2026)
        6.3.2 United States New Psychoactive Substance Market Size and Forecast (2016-2026)
        6.3.3 Canada New Psychoactive Substance Market Size and Forecast (2016-2026)
        6.3.4 Mexico New Psychoactive Substance Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe New Psychoactive Substance Revenue by Type (2016-2026)
    7.2 Europe New Psychoactive Substance Revenue by Application (2016-2026)
    7.3 Europe New Psychoactive Substance Market Size by Country
        7.3.1 Europe New Psychoactive Substance Revenue by Country (2016-2026)
        7.3.2 Germany New Psychoactive Substance Market Size and Forecast (2016-2026)
        7.3.3 France New Psychoactive Substance Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom New Psychoactive Substance Market Size and Forecast (2016-2026)
        7.3.5 Russia New Psychoactive Substance Market Size and Forecast (2016-2026)
        7.3.6 Italy New Psychoactive Substance Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific New Psychoactive Substance Revenue by Type (2016-2026)
    8.2 Asia-Pacific New Psychoactive Substance Revenue by Application (2016-2026)
    8.3 Asia-Pacific New Psychoactive Substance Market Size by Region
        8.3.1 Asia-Pacific New Psychoactive Substance Revenue by Region (2016-2026)
        8.3.2 China New Psychoactive Substance Market Size and Forecast (2016-2026)
        8.3.3 Japan New Psychoactive Substance Market Size and Forecast (2016-2026)
        8.3.4 South Korea New Psychoactive Substance Market Size and Forecast (2016-2026)
        8.3.5 India New Psychoactive Substance Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia New Psychoactive Substance Market Size and Forecast (2016-2026)
        8.3.7 Australia New Psychoactive Substance Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America New Psychoactive Substance Revenue by Type (2016-2026)
    9.2 South America New Psychoactive Substance Revenue by Application (2016-2026)
    9.3 South America New Psychoactive Substance Market Size by Country
        9.3.1 South America New Psychoactive Substance Revenue by Country (2016-2026)
        9.3.2 Brazil New Psychoactive Substance Market Size and Forecast (2016-2026)
        9.3.3 Argentina New Psychoactive Substance Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa New Psychoactive Substance Revenue by Type (2016-2026)
    10.2 Middle East & Africa New Psychoactive Substance Revenue by Application (2016-2026)
    10.3 Middle East & Africa New Psychoactive Substance Market Size by Country
        10.3.1 Middle East & Africa New Psychoactive Substance Revenue by Country (2016-2026)
        10.3.2 Turkey New Psychoactive Substance Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia New Psychoactive Substance Market Size and Forecast (2016-2026)
        10.3.4 UAE New Psychoactive Substance Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global New Psychoactive Substance Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global New Psychoactive Substance Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market New Psychoactive Substance Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global New Psychoactive Substance Revenue (USD Million) by Region (2016-2021)
    Table 5. Global New Psychoactive Substance Revenue Market Share by Region (2021-2026)
    Table 6. Zynerba Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 7. Zynerba Pharmaceuticals Major Business
    Table 8. Zynerba Pharmaceuticals New Psychoactive Substance Product and Solutions
    Table 9. Zynerba Pharmaceuticals New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. GW Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 11. GW Pharmaceuticals Major Business
    Table 12. GW Pharmaceuticals New Psychoactive Substance Product and Solutions
    Table 13. GW Pharmaceuticals New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Teewinot Life Sciences Corporate Information, Head Office, and Major Competitors
    Table 15. Teewinot Life Sciences Major Business
    Table 16. Teewinot Life Sciences New Psychoactive Substance Product and Solutions
    Table 17. Teewinot Life Sciences New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. AusCann Corporate Information, Head Office, and Major Competitors
    Table 19. AusCann Major Business
    Table 20. AusCann New Psychoactive Substance Product and Solutions
    Table 21. AusCann New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Cannabics Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 23. Cannabics Pharmaceuticals Major Business
    Table 24. Cannabics Pharmaceuticals New Psychoactive Substance Product and Solutions
    Table 25. Cannabics Pharmaceuticals New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Tilray Corporate Information, Head Office, and Major Competitors
    Table 27. Tilray Major Business
    Table 28. Tilray New Psychoactive Substance Product and Solutions
    Table 29. Tilray New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Cyrelian Corporate Information, Head Office, and Major Competitors
    Table 31. Cyrelian Major Business
    Table 32. Cyrelian New Psychoactive Substance Product and Solutions
    Table 33. Cyrelian New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Anandia Laboratories Corporate Information, Head Office, and Major Competitors
    Table 35. Anandia Laboratories Major Business
    Table 36. Anandia Laboratories New Psychoactive Substance Product and Solutions
    Table 37. Anandia Laboratories New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. InMed Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 39. InMed Pharmaceuticals Major Business
    Table 40. InMed Pharmaceuticals New Psychoactive Substance Product and Solutions
    Table 41. InMed Pharmaceuticals New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Renew Biopharma Corporate Information, Head Office, and Major Competitors
    Table 43. Renew Biopharma Major Business
    Table 44. Renew Biopharma New Psychoactive Substance Product and Solutions
    Table 45. Renew Biopharma New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. Cronos Group Corporate Information, Head Office, and Major Competitors
    Table 47. Cronos Group Major Business
    Table 48. Cronos Group New Psychoactive Substance Product and Solutions
    Table 49. Cronos Group New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. ICC International Cannabis Corporate Information, Head Office, and Major Competitors
    Table 51. ICC International Cannabis Major Business
    Table 52. ICC International Cannabis New Psychoactive Substance Product and Solutions
    Table 53. ICC International Cannabis New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 54. Biotii Technologies Corporate Information, Head Office, and Major Competitors
    Table 55. Biotii Technologies Major Business
    Table 56. Biotii Technologies New Psychoactive Substance Product and Solutions
    Table 57. Biotii Technologies New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 58. Global New Psychoactive Substance Revenue (USD Million) by Players (2019-2021)
    Table 59. Global New Psychoactive Substance Revenue Share by Players (2019-2021)
    Table 60. Breakdown of New Psychoactive Substance by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 61. New Psychoactive Substance Players Head Office, Products and Services Provided
    Table 62. New Psychoactive Substance Mergers & Acquisitions in the Past Five Years
    Table 63. New Psychoactive Substance New Entrants and Expansion Plans
    Table 64. Global New Psychoactive Substance Revenue (USD Million) by Type (2016-2021)
    Table 65. Global New Psychoactive Substance Revenue Share by Type (2016-2021)
    Table 66. Global New Psychoactive Substance Revenue Forecast by Type (2021-2026)
    Table 67. Global New Psychoactive Substance Revenue by Application (2016-2021)
    Table 68. Global New Psychoactive Substance Revenue Forecast by Application (2021-2026)
    Table 69. North America New Psychoactive Substance Revenue by Type (2016-2021) & (USD Million)
    Table 70. North America New Psychoactive Substance Revenue by Type (2021-2026) & (USD Million)
    Table 71. North America New Psychoactive Substance Revenue by Application (2016-2021) & (USD Million)
    Table 72. North America New Psychoactive Substance Revenue by Application (2021-2026) & (USD Million)
    Table 73. North America New Psychoactive Substance Revenue by Country (2016-2021) & (USD Million)
    Table 74. North America New Psychoactive Substance Revenue by Country (2021-2026) & (USD Million)
    Table 75. Europe New Psychoactive Substance Revenue by Type (2016-2021) & (USD Million)
    Table 76. Europe New Psychoactive Substance Revenue by Type (2021-2026) & (USD Million)
    Table 77. Europe New Psychoactive Substance Revenue by Application (2016-2021) & (USD Million)
    Table 78. Europe New Psychoactive Substance Revenue by Application (2021-2026) & (USD Million)
    Table 79. Europe New Psychoactive Substance Revenue by Country (2016-2021) & (USD Million)
    Table 80. Europe New Psychoactive Substance Revenue by Country (2021-2026) & (USD Million)
    Table 81. Asia-Pacific New Psychoactive Substance Revenue by Type (2016-2021) & (USD Million)
    Table 82. Asia-Pacific New Psychoactive Substance Revenue by Type (2021-2026) & (USD Million)
    Table 83. Asia-Pacific New Psychoactive Substance Revenue by Application (2016-2021) & (USD Million)
    Table 84. Asia-Pacific New Psychoactive Substance Revenue by Application (2021-2026) & (USD Million)
    Table 85. Asia-Pacific New Psychoactive Substance Revenue by Region (2016-2021) & (USD Million)
    Table 86. Asia-Pacific New Psychoactive Substance Revenue by Region (2021-2026) & (USD Million)
    Table 87. South America New Psychoactive Substance Revenue by Type (2016-2021) & (USD Million)
    Table 88. South America New Psychoactive Substance Revenue by Type (2021-2026) & (USD Million)
    Table 89. South America New Psychoactive Substance Revenue by Application (2016-2021) & (USD Million)
    Table 90. South America New Psychoactive Substance Revenue by Application (2021-2026) & (USD Million)
    Table 91. South America New Psychoactive Substance Revenue by Country (2016-2021) & (USD Million)
    Table 92. South America New Psychoactive Substance Revenue by Country (2021-2026) & (USD Million)
    Table 93. Middle East & Africa New Psychoactive Substance Revenue by Type (2016-2021) & (USD Million)
    Table 94. Middle East & Africa New Psychoactive Substance Revenue by Type (2021-2026) & (USD Million)
    Table 95. Middle East & Africa New Psychoactive Substance Revenue by Application (2016-2021) & (USD Million)
    Table 96. Middle East & Africa New Psychoactive Substance Revenue by Application (2021-2026) & (USD Million)
    Table 97. Middle East & Africa New Psychoactive Substance Revenue by Country (2016-2021) & (USD Million)
    Table 98. Middle East & Africa New Psychoactive Substance Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. New Psychoactive Substance Picture
    Figure 2. Global New Psychoactive Substance Revenue Market Share by Type in 2020
    Figure 3. Stimulants
    Figure 4. Cannabinoids
    Figure 5. Hallucinogens
    Figure 6. Depressants
    Figure 7. New Psychoactive Substance Revenue Market Share by Application in 2020
    Figure 8. Cancer Picture
    Figure 9. Neuropathic Disorders Picture
    Figure 10. Spasticity Picture
    Figure 11. Others Picture
    Figure 12. Global New Psychoactive Substance Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 13. Global New Psychoactive Substance Revenue and Forecast (2016-2026) & (USD Million)
    Figure 14. Global New Psychoactive Substance Revenue Market Share by Region (2016-2026)
    Figure 15. Global New Psychoactive Substance Revenue Market Share by Region in 2020
    Figure 16. North America New Psychoactive Substance Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. Europe New Psychoactive Substance Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. Asia-Pacific New Psychoactive Substance Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 19. South America New Psychoactive Substance Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 20. Middle East and Africa New Psychoactive Substance Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 21. New Psychoactive Substance Market Drivers
    Figure 22. New Psychoactive Substance Market Restraints
    Figure 23. New Psychoactive Substance Market Trends
    Figure 24. Zynerba Pharmaceuticals Recent Developments and Future Plans
    Figure 25. GW Pharmaceuticals Recent Developments and Future Plans
    Figure 26. Teewinot Life Sciences Recent Developments and Future Plans
    Figure 27. AusCann Recent Developments and Future Plans
    Figure 28. Cannabics Pharmaceuticals Recent Developments and Future Plans
    Figure 29. Tilray Recent Developments and Future Plans
    Figure 30. Cyrelian Recent Developments and Future Plans
    Figure 31. Anandia Laboratories Recent Developments and Future Plans
    Figure 32. InMed Pharmaceuticals Recent Developments and Future Plans
    Figure 33. Renew Biopharma Recent Developments and Future Plans
    Figure 34. Cronos Group Recent Developments and Future Plans
    Figure 35. ICC International Cannabis Recent Developments and Future Plans
    Figure 36. Biotii Technologies Recent Developments and Future Plans
    Figure 37. Global New Psychoactive Substance Revenue Share by Players in 2020
    Figure 38. New Psychoactive Substance Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 39. Global Top 3 Players New Psychoactive Substance Revenue Market Share in 2020
    Figure 40. Global Top 10 Players New Psychoactive Substance Revenue Market Share in 2020
    Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 42. Global New Psychoactive Substance Revenue Share by Type in 2020
    Figure 43. Global New Psychoactive Substance Market Share Forecast by Type (2021-2026)
    Figure 44. Global New Psychoactive Substance Revenue Share by Application in 2020
    Figure 45. Global New Psychoactive Substance Market Share Forecast by Application (2021-2026)
    Figure 46. North America New Psychoactive Substance Sales Market Share by Type (2016-2026)
    Figure 47. North America New Psychoactive Substance Sales Market Share by Application (2016-2026)
    Figure 48. North America New Psychoactive Substance Revenue Market Share by Country (2016-2026)
    Figure 49. United States New Psychoactive Substance Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Canada New Psychoactive Substance Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Mexico New Psychoactive Substance Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Europe New Psychoactive Substance Sales Market Share by Type (2016-2026)
    Figure 53. Europe New Psychoactive Substance Sales Market Share by Application (2016-2026)
    Figure 54. Europe New Psychoactive Substance Revenue Market Share by Country (2016-2026)
    Figure 55. Germany New Psychoactive Substance Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. France New Psychoactive Substance Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. United Kingdom New Psychoactive Substance Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Russia New Psychoactive Substance Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Italy New Psychoactive Substance Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Asia-Pacific New Psychoactive Substance Sales Market Share by Type (2016-2026)
    Figure 61. Asia-Pacific New Psychoactive Substance Sales Market Share by Application (2016-2026)
    Figure 62. Asia-Pacific New Psychoactive Substance Revenue Market Share by Region (2016-2026)
    Figure 63. China New Psychoactive Substance Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. Japan New Psychoactive Substance Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. South Korea New Psychoactive Substance Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. India New Psychoactive Substance Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Southeast Asia New Psychoactive Substance Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Australia New Psychoactive Substance Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. South America New Psychoactive Substance Sales Market Share by Type (2016-2026)
    Figure 70. South America New Psychoactive Substance Sales Market Share by Application (2016-2026)
    Figure 71. South America New Psychoactive Substance Revenue Market Share by Country (2016-2026)
    Figure 72. Brazil New Psychoactive Substance Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Argentina New Psychoactive Substance Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Middle East and Africa New Psychoactive Substance Sales Market Share by Type (2016-2026)
    Figure 75. Middle East and Africa New Psychoactive Substance Sales Market Share by Application (2016-2026)
    Figure 76. Middle East and Africa New Psychoactive Substance Revenue Market Share by Country (2016-2026)
    Figure 77. Turkey New Psychoactive Substance Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. Saudi Arabia New Psychoactive Substance Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. UAE New Psychoactive Substance Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 80. Methodology
    Figure 81. Research Process and Data Source

Companies Mentioned

Zynerba Pharmaceuticals
GW Pharmaceuticals
Teewinot Life Sciences
AusCann
Cannabics Pharmaceuticals
Tilray
Cyrelian
Anandia Laboratories
InMed Pharmaceuticals
Renew Biopharma
Cronos Group
ICC International Cannabis
Biotii Technologies